BioDlink and Lepu Biopharma mark a significant milestone with the launch of MEIYOUHENG®, the first EGFR-targeting ADC drug, showcasing their collaborative achievement in biologics.

Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their partnership spanning over two years. Demonstrating Robust Capabilities: Throughout the collaboration, all technology transfers and GMP...